Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker
Author:
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s00280-020-04145-6.pdf
Reference36 articles.
1. Jodrell DI, Egorin MJ, Canetta RM, Langenberg P, Goldbloom EP, Burroughs JN, Goodlow JL, Tan S, Wiltshaw E (1992) Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 10(4):520–528
2. Bristol-Myers Squibb Company (2010) Package Insert—PARAPLATIN® (carboplatin) for Injection, USP
3. Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7(11):1748–1756. https://doi.org/10.1200/JCO.1989.7.11.1748
4. Casal MA, Nolin TD, Beumer JH (2019) Estimation of kidney function in oncology. Clin J Am Soc Nephrol. https://doi.org/10.2215/cjn.11721018
5. Levey AS, Inker LA, Coresh J (2014) GFR estimation: from physiology to public health. Am J Kidney Dis 63(5):820–834. https://doi.org/10.1053/j.ajkd.2013.12.006
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Optimizing Timing of Intraperitoneal Chemotherapy to Enhance Intravenous Carboplatin Concentration;Cancers;2024-08-14
2. Study on Cytochrome P450 Metabolic Profile of Paclitaxel on Rats using QTOF-MS;Current Drug Metabolism;2024-07-19
3. Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer;BMC Cancer;2022-12-22
4. Glomerular filtration rate in critically ill neonates and children: creatinine-based estimations versus iohexol-based measurements;Pediatric Nephrology;2022-08-02
5. Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study;Journal of Clinical Oncology;2021-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3